Thomas Quertermous
Amgen Inc.
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Single-cell and spatial transcriptomics
Strong evidence · 7 supporting papers · latest 2026
Angiogenesis and VEGF in Cancer
Strong evidence · 2 supporting papers · latest 2026
Atherosclerosis and Cardiovascular Diseases
Strong evidence · 5 supporting papers · latest 2026
Cell Adhesion Molecules Research
Strong evidence · 1 supporting paper · latest 2025
RNA regulation and disease
Strong evidence · 1 supporting paper · latest 2026
Congenital heart defects research
Solid evidence · 7 supporting papers · latest 2026
Peptidase Inhibition and Analysis
Solid evidence · 1 supporting paper · latest 2026
Parathyroid Disorders and Treatments
Solid evidence · 1 supporting paper · latest 2026
Publications (15)
A cell and transcriptome atlas of human arterial vasculature
2025DOIPMID 41086809
Single-Cell Studies Advance Understanding of the Genetic and Molecular Basis of Atherosclerosis
2026DOIPMID 42283082
Adenosine-to-Inosine (A-to-I) RNA Editing by ADAR1 to Control RNA Sensing in Cardiovascular Disease
2026DOIPMID 41744067
Transcriptomic, Specific Marker, and Pathway Analysis of Smooth Muscle Cell Foam Cells Relative to Macrophage Foam Cells in Human Atherosclerosis
2026DOIPMID 42282821
Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk
2026DOIPMID 41844614
A Perturb-seq screen guided by species divergence uncovers pathways for collateral artery formation
2026DOIPMID 42146601
Abstract 4358524: The epigenomic landscape of single vascular cells reflects developmental origin and identifies disease risk loci
2025DOI
An in vitro System for Studying Osteochondrogenic Differentiation of Smooth Muscle Cells and Modeling Intimal Vascular Calcification
2026DOI
Abstract 4370980: Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk
2025DOI
Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy
2026DOIPMID 41610194
Abstract 4358726: ZEB1 Regulates Coronary Disease Risk Through Epigenetic Control of Smooth Muscle Cell Identity
2025DOI
FOXC1 Controls Smooth Muscle Cell Differentiation and Plasticity in Vascular Disease
2026DOIPMID 42127570
Abstract Or137: Systematic Mapping of Smooth Muscle Cell Gene Programs That Drive Genetic Risk for Coronary Artery Disease
2026DOI
Abstract Or120: Dedicated Smooth Muscle Progenitor Populations, Marked by Notch3 and Sox9, Show Distinct Atherosclerotic Plaque Fate
2026DOI
Functional Genomics Link REST to Endothelial Plasticity and Atherosclerosis
2025DOIPMID 41293823
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Amgen Inc.
Source: OpenAlex · retrieved 2026-09-29